DERM Journey Medical Corporation

$7.23▲ +1.97% Healthcare Other
After hours $7.23▲ +0.00% Sep 11, 4:10 PM ET
Volume 168.0K Avg Volume (10D) 115.4K
Key Metrics & Fundamentals
Market Cap
$204.06M
P/E Ratio
–
Div Yield
–%
52W Range
4.31 - 9.56
% vs 50 MA
3.49%
% vs 200 MA
4.23%
RSI-14
49.3
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.75
Free Cash Flow
-$1.73M
Gross Rev
$18.51M
Gross Profit
$12.37M
EBITDA
$1.60M
COGS
$6.14M
Operating Exp
$11.91M
Operating Income
$456,000
EBIT
$456,000
Pretax Income
-$297,000
Net Income
-$312,000
EPS (Diluted)
-0.01
Price & Volume History
Loading chart…
Recent News
Journey Medical Corporation to Participate in September 2026 Investor Conferences
GlobeNewswire · Sep 8, 2026 8:05 PM
Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories
GlobeNewswire · Aug 31, 2026 9:05 AM
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
Zacks · Aug 25, 2026 3:20 PM
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 9:58 PM
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
GlobeNewswire · Aug 19, 2026 8:05 PM
--B. Riley Adjusts Journey Medical Price Target to $15 From $12, Maintains Buy Rating
MT Newswires · Aug 13, 2026 12:09 PM
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ...
GuruFocus.com · Aug 13, 2026 5:02 AM
Journey Medical Corporation Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 1:04 AM
Fortress Biotech Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 11:04 PM
Journey Medical Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 11:04 PM
Financial Overview - Income Statement Quarterly

See DERM's money flow as a full page

Social Sentiment
Avg -0.07 · 3 posts
HIMS: FDA letter + Patent suit + reported DOJ referral
r/stocks · Feb 13, 2026
The post expresses strong criticism regarding the CEO's actions, legal troubles, and financial instability, indicating a bearish sentiment towards the company and its stock.
negative -0.60
HIMS Might be Undervalued by ~ 20%?
r/stocks · Dec 25, 2025
The post expresses significant skepticism about HIMS's business model, highlighting concerns about profitability, competition, and the replicability of its business, indicating a bearish outlook.
negative -0.50
DDNewsPriceTargetDONT SLEEP ON $DERM. I believe we’ll see at least $100 by the end of 2026!!!
r/wallstreetbets · Aug 12, 2025
Strong bullish sentiment due to analyst ratings, product launch, and clinical trial data.
very_positive +0.90
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙